Akero Therapeutics earnings were -$252.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AKRO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$70.0M, down 3.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AKRO reported annual earnings of -$252.1M, with 66.1% growth. The next AKRO earnings date is May 8, 2025.
What were Akero Therapeutics's earnings last quarter?
On AKRO's earnings call on Invalid Date, Akero Therapeutics (NASDAQ: AKRO) reported Q4 2024 earnings per share (EPS) of -$0.99, up 2.94% year over year. Total AKRO earnings for the quarter were -$70.02 million. In the same quarter last year, Akero Therapeutics's earnings per share (EPS) was -$1.02.
The next AKRO earnings date is Invalid Date. Add AKRO to your watchlist to be reminded of Akero Therapeutics's next earnings date.
What was AKRO's earnings growth in the past year?
As of Akero Therapeutics's earnings date in Invalid Date, Akero Therapeutics's earnings has grown year over year. AKRO earnings in the past year totalled -$252.06 million.
Is Akero Therapeutics profitable or losing money?
As of the last Akero Therapeutics earnings report, Akero Therapeutics is currently losing money. Akero Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$252.06 million, a 66.09% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.